Charles Dujon is named as a lobbyist on federal disclosure filings for 3 clients through 2359 Strategies. The most recent filing naming them posted in April 2025. Issues reported include Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs and Pharmacy.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| THE FIBROID FOUNDATION | 2359 STRATEGIES | Q1 2025 | Defense, Health Issues |
| FEDERAL STREET STRATEGIES LLC | 2359 STRATEGIES | Q1 2025 | Telecommunications, Communications/Broadcasting/Radio/TV, Labor Issues/Antitrust/Workplace |
| TRAVERE THERAPEUTICS | 2359 STRATEGIES | Q1 2025 | Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code, Medicare/Medicaid |
| Year | Clients | Registrants |
|---|---|---|
| 2025 | 3 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Charles Dujon. See the Capitol Clarity rankings and method.